Intuitive Surgical, Inc. $ISRG Shares Sold by Focus Partners Advisor Solutions LLC

Focus Partners Advisor Solutions LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.9% during the fourth quarter, Holdings Channel reports. The firm owned 3,341 shares of the medical equipment provider’s stock after selling 1,295 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in Intuitive Surgical were worth $1,892,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Cerity Partners LLC raised its holdings in shares of Intuitive Surgical by 5.2% during the fourth quarter. Cerity Partners LLC now owns 172,941 shares of the medical equipment provider’s stock worth $97,947,000 after purchasing an additional 8,584 shares during the period. LPL Financial LLC raised its holdings in shares of Intuitive Surgical by 5.3% during the fourth quarter. LPL Financial LLC now owns 455,070 shares of the medical equipment provider’s stock worth $257,734,000 after purchasing an additional 22,774 shares during the period. Doheny Asset Management CA acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $203,000. Deepwater Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $14,278,000. Finally, O Shaughnessy Asset Management LLC raised its holdings in shares of Intuitive Surgical by 19.2% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 62,192 shares of the medical equipment provider’s stock worth $35,223,000 after purchasing an additional 10,031 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: ISRG was upgraded to a Zacks Rank #2 (Buy), signaling improving earnings expectations and adding a bullish catalyst for the stock.
• Positive Sentiment: Analysts say Intuitive Surgical can use its scale, cost discipline, and growing da Vinci 5 adoption to offset tariff and input-cost pressure, which supports the company’s margin outlook.
• Positive Sentiment: The stock also recently outperformed the broader market, reflecting continued investor confidence in its growth profile. Article: Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
• Neutral Sentiment: Two executives sold shares under pre-arranged Rule 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they may be viewed more as portfolio management than a major red flag.
• Neutral Sentiment: Analyst commentary also noted that ISRG’s fair value estimate was reset lower, which suggests some caution remains despite the company’s long-term growth story.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a report on Tuesday, June 2nd. TD Cowen lowered their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Finally, Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $412.02 on Thursday. The company has a 50-day simple moving average of $444.91 and a 200-day simple moving average of $497.84. The firm has a market capitalization of $145.92 billion, a P/E ratio of 49.94, a P/E/G ratio of 3.41 and a beta of 1.46. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.81 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 500 shares of the stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the transaction, the director owned 239 shares in the company, valued at $113,156.94. This represents a 67.66% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This represents a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,144 shares of company stock worth $3,048,782 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.